An intriguing question for future studies is whether uPAR-beta-integrin signalling may contribute to this discrepancy, especially as association of these factors have been linked to cancer progression [39] and may influence invasion of prostate metastatic cells [40]. This evidence concerns the gene PLAUR and cancer.